Shortage of NYXOID naloxone hydrochloride dihydrate 2.2 mg/actuation nasal spray vial

Dear Healthcare Professional,

Shortage of NYXOID naloxone hydrochloride dihydrate 2.2 mg/actuation nasal spray vial (AUST R: 309381)

Pro Pharmaceuticals Group recognises the importance of supplying essential medicines in Australia and would like to advise you the change in supply status of NYXOID naloxone hydrochloride dihydrate 2.2 mg/actuation nasal spray vial (AUST R: 309381) in Australia.

The Australian registered medicine, NYXOID naloxone hydrochloride dihydrate 2.2 mg/actuation nasal spray vial (AUST R: 309381) is currently in shortage due to an unexpected increase in consumer demand.

Pro Pharmaceuticals Group has arranged for the supply of an alternative product, NYXOID naloxone 1.8mg nasal spray solution in a single-dose container (UK). This product is NOT registered in Australia and supply is authorised under an exemption granted by the Therapeutic Goods Administration (TGA) under section 19A of the Therapeutic Goods Act 1989 until 31st October 2023

Registered Pro Pharm Member Pharmacies can Log into our website www.propg.com.au and visit Pharmacy Online Ordering to see Product Details including Pricing, Availability and also do any Pre-Orders.

Not a Registered Pro Pharm Member? Then Register Today by visiting our website and going to Pharmacy Online Ordering.

Please note Pro Pharmaceuticals Group is a Wholesaler and not a Pharmacy and can not supply to members of the Public, if you are a member of the Public please visit your Pharmacy to discuss.

This product is now PBS Listed Sept 1st 2023